SEARCH

SEARCH BY CITATION

References

  • Asselin, B.L., Whitin, J.C., Coppola, D.J., Rupp, I.P., Sallan, S.E., Cohen, H.J. (1993a) Comparative pharmacokinetic studies of three asparaginase preparations. Journal of Clinical Oncology, 11, 1780 1786.
  • Asselin, B., Gelber, R., Sallan, S. (1993b) Relative toxicity of E. colil-asparaginase (ASP) and PEG asparaginase (PEG) in newly diagnosed childhood acute lymphoblastic leukemia (ALL) . Medical and Pediatric Oncology, 21, 556.
  • Beal, S.L. & Sheiner, L.B. (eds) (1992) NONMEM User's Guides. NONMEM Project Group, University of California at San Francisco, San Francisco.
  • Becker, F.F. & Broome, J.D. (1969) l-asparaginase: inhibition of endogenous RNA polymerase activity in regenerating liver . Archives in Biochemistry and Biophysics, 130, 332 336.
  • Boos, J. & Jürgens, H. (1996) Pegaspargase (polyethylene glycol- l-asparaginase) a viewpoint by Joachim Boos and Herbert Jürgens . Clinical Immunotherapeutics, 5, 497 498.
  • Boos, J., Werber, G., Ahlke, E., Schulze-Westhoff, P., Nowak-Göttl, U., Würthwein, G., Verspohl, E.J., Ritter, J., Jürgens, H. (1996) Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. European Journal of Cancer, 32A, 1544 1550.
  • Broome, J.D. (1981) l-Asparaginase: discovery and development as a tumor-inhibitory agent . Cancer Treatment Reports, 65, 111 114.
  • Bussolati, O., Belletti, S., Uggeri, J., Gatti, R., Orlandi, G., Dall'asta, V., Gazzola, G.C. (1995) Characterization of apoptotic phenomena induced by treatment with l-asparaginase in NIH-3T3 cells . Experimental Cell Research, 220, 283 291.DOI: 10.1006/excr.1995.1317
  • Cheung, Y.F., Lee, C.W., Chan, C.F., Chan, K.L., Lau, Y.L., Cheung, C.Y. (1994) Somatostatin therapy in l-asparaginase-induced pancreatitis . Medical and Pediatric Oncology, 22, 421 424.
  • Dellinger, C.T. & Miale, T.D. (1976) Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures. Cancer, 38, 1843 1846.
  • Eden, O.B., Shaw, M.P., Lilleyman, J.S., Richards, S. (1990) Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukemia. Medical and Pediatric Oncology, 18, 497 502.
  • Fabry, U., Körholz, D., Jürgens, H., Göbel, U., Wahn, V. (1985) Anaphylaxis to l-asparaginase during treatment for acute lymphoblastic leukemia in children – evidence of a complement-mediated mechanism. Pediatric Research, 19, 400 408.
  • Frankel, S.R., Kurtzberg, J., DeOleivera, D., Dodge, R., Peterson, B., Powell, B.L., Larson, R.A., Schiffer, C.A. (1996) Toxicity and pharmacokinetics of PEG-asparaginase (PEG-asp) in newly diagnosed adult acute lymphoblastic leukemia (ALL): CALGB 9511. Blood, 88 (Suppl. 1/1), 669a.
  • Jones, B., Holland, J.F., Glidewell, O., Jacquillat, C., Weil, M., Pochedly, C., Sinks, L., Chevalier, L., Maurer, H.M., Koch, K., Falkson, G., Patterson, R., Seligman, B., Satorius, J., Kung, F., Haurani, F., Stuart, M., Bugert, O., Ruymann, F., Sawitsky, A., Forman, E., Pluess, H., Truman, J., Hakami, N. (1977) Optimal use of l-asparaginase (NSC-109229) in acute lymphocytic leukemia . Medical and Pediatric Oncology, 3, 387 400.
  • Keating, M.J., Holmes, R., Lerner, S., Ho, D.H. (1993) l-Asparaginase and PEG asparaginase – past, present and future. Leukemia and Lymphoma, 10, 153 157.
  • Killander, D., Dohlwitz, A., Engstedt, L., Franzen, S., Gahrton, G., Gullbring, B., Holm, G., Holmgren, A., Höglund, S., Killander, A., Lockner, D., Mellstedt, H., Moe, P.J., Palmblad, J., Reizenstein, P., Skarberg, K.O., Swedberg, B., Uden, A.M., Wadman, B., Wide, M., Ahström, L. (1976) Hypersensitive reactions and antibody formation during l-asparaginase treatment of children and adults with acute leukemia . Cancer, 37, 220 228.
  • Kurtzberg, J., Asselin, B., Poplack, D., Grebanier, A., Chen, R., Franklin, A., Scudiery, D., Fisherman, J. (1993) Antibodies to asparaginase alter pharmacokinetics and decrease enzyme activity in patients on asparaginase therapy. Proceedings of the American Association for Cancer Research, 34, 304.
  • Miller, H.K., Salser, J.S., Balis, M.E. (1969) Amino acid levels following l-asparagine amidohydrolase (EC 3.5.1.1.) therapy . Cancer Research, 29, 183 187.
  • Minton, N.P., Bullman, H.M.S., Scawen, M.D., Atkinson, T., Gilbert, H.J. (1986) Nucleotide sequence of the Erwinia chrysanthemi NCPPB 1066 l-asparaginase gene . Gene, 46, 25 35.
  • Nowak-Göttl, U., Werber, G., Ziemann, D. (1996) Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL. Haematologica, 81, 127 131.
  • Ohnuma, T., Holland, J.F., Freeman. A. (1970) Biochemical and pharmacological studies with asparaginase in man. Cancer Research, 30, 2297 2305.
  • Pratt, C.B., Simone, J.V., Zee, P., Aur, R.J.A., Johnson, W.W. (1970) Comparison of daily versus weekly l-asparaginase for the treatment of childhood acute leukemia . Journal of Pediatrics, 77, 474 483.
  • Reiter, A., Tiemann, M., Ludwig, W.D., Wacker, H.H., Yakisan, E., Schrappe, M., Henzler, D., Sykora, K.W., Brandt, A., Odenwald, E., Riehm, H., Parwaresch, R. (1994) Therapiestudie NHL-BFM 90 zur Behandlung maligner Non-Hodgkin-Lymphome bei Kindern und Jugendlichen. Teil 1: Klassifikation und Einteilung in strategische Therapiegruppen. Klinische Pädiatrie, 206, 222 233.
  • Riccardi, R., Holcenberg, J.S., Glaubinger, D.L., Wood, J.H., Poplack, D.G. (1981) l-Asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans . Cancer Research, 41, 4554 4558.
  • Schrappe, M., Reiter, A., Sauter, S., Ludwig, W.D., Wörmann, B., Harbott, J., Bender-Götze, C., Dörffel, W., Dopfer, R., Frey, E., Havers, W., Henze, G., Kühl, J., Richter, R., Ritter, J., Treuner, J., Zintl, F., Odenwald, E., Welte, K., Riehm, H. (1994) Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark. Klinische Pädiatrie, 206, 208 221.
  • Story, M.D., Voehringer, D.W., Stephens, L.C., Meyn, R.E. (1993) l-Asparaginase kills lymphoma cells by apoptosis . Cancer Chemotherapy and Pharmacology, 32, 129 133.
  • Vieira Pinheiro, J.P., Ahlke, E., Nowak-Göttl, U., Hempel, G., Müller, H.J., Lümkemann, K., Schrappe, M., Rath, B., Fleischhack, G., Mann, G., Boos, J. (1999) Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols . British Journal of Haematology, 104, 313 320.
  • Werber, G., Ahlke, E., Nowak-Göttl, U., Jürgens, H., Verspohl, E.J., Boos, J. (1997) Asparaginase activities in vitro are highly sensitive to different buffer conditions. In: Acute Leukemias VI: Prognostic Factors and Treatment Strategies (ed. by Büchner et al.), pp. 512 516. Springer, Berlin.
  • Wriston, Jr, J.C. & Yellin, T.O. (1973) L-Asparaginase: review. Advances in Enzymology and Related Areas of Molecular Biology, 39, 185 248.